JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB47339

Anti-ERK1 (phospho Y204) + ERK2 (phospho Y187) antibody

5

(2 Reviews)

|

(27 Publications)

Rabbit Polyclonal ERK2 phospho Y187 antibody. Suitable for WB, IHC-P and reacts with Human samples. Cited in 27 publications. Immunogen corresponding to Synthetic Peptide within Human MAPK1 phospho Y187.

View Alternative Names

ERK2, PRKM1, PRKM2, MAPK1, Mitogen-activated protein kinase 1, MAP kinase 1, MAPK 1, ERT1, Extracellular signal-regulated kinase 2, MAP kinase isoform p42, Mitogen-activated protein kinase 2, ERK-2, p42-MAPK, MAP kinase 2, MAPK 2

3 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-ERK1 (phospho Y204) + ERK2 (phospho Y187) antibody (AB47339)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-ERK1 (phospho Y204) + ERK2 (phospho Y187) antibody (AB47339)

ab47339 staining human normal or colon tissue. Staining is localised to cytoplasm.
Left panel : with primary antibody at 2 ug/ml. Right panel : isotype control.
Sections were stained using an automated system DAKO Autostainer Plus , at room temperature. Sections were rehydrated and antigen retrieved with the Dako 3-in-1 AR buffer EDTA pH 9.0 in a DAKO PT Link. Slides were peroxidase blocked in 3% H2O2 in methanol for 10 minutes. They were then blocked with Dako Protein block for 10 minutes (containing casein 0.25% in PBS) then incubated with primary antibody for 20 minutes and detected with Dako Envision Flex amplification kit for 30 minutes. Colorimetric detection was completed with diaminobenzidine for 5 minutes. Slides were counterstained with Haematoxylin and coverslipped under DePeX. Please note that for manual staining we recommend to optimize the primary antibody concentration and incubation time (overnight incubation), and amplification may be required.

Western blot - Anti-ERK1 (phospho Y204) + ERK2 (phospho Y187) antibody (AB47339)
  • WB

Unknown

Western blot - Anti-ERK1 (phospho Y204) + ERK2 (phospho Y187) antibody (AB47339)

All lanes:

Western blot - Anti-ERK1 (phospho Y204) + ERK2 (phospho Y187) antibody (ab47339)

Lane 1:

Jurkat cell extract

Lane 2:

Jurkat cell extract treated with PMA

Observed band size: 43 kDa

false

Western blot - Anti-ERK1 (phospho Y204) + ERK2 (phospho Y187) antibody (AB47339)
  • WB

Unknown

Western blot - Anti-ERK1 (phospho Y204) + ERK2 (phospho Y187) antibody (AB47339)

All lanes:

Western blot - Anti-ERK1 (phospho Y204) + ERK2 (phospho Y187) antibody (ab47339) at 1/500 dilution

Lane 1:

Extracts from Jurkat cells treated with PMA (200ng/ml, 15min)

Lane 2:

Extracts from Jurkat cells un-treated

Observed band size: 42 kDa,44 kDa

false

Key facts

Host species

Rabbit

Clonality

Polyclonal

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

WB, IHC-P

applications

Immunogen

Synthetic Peptide within Human MAPK1 phospho Y187. The exact immunogen used to generate this antibody is proprietary information.

P28482

Specificity

This antibody is specific for ERK1, only when phosphorylated at tyrosine 204

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/500 - 1/1000", "WB-species-notes": "<p></p>", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p></p>" }, "Mouse": { "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "", "IHCP-species-checked": "predicted", "IHCP-species-dilution-info": "", "IHCP-species-notes": "" }, "Rat": { "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "", "IHCP-species-checked": "predicted", "IHCP-species-dilution-info": "", "IHCP-species-notes": "" } } }

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Immunogen
Purification notes
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific phosphopeptide. The antibody against non-phosphopeptide was removed by chromatography using non-phosphopeptide corresponding to the phosphorylation site.
Storage buffer
pH: 7.4 Preservative: 0.02% Sodium azide Constituents: PBS, 50% Glycerol (glycerin, glycerine), 0.87% Sodium chloride
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

ERK1 and ERK2 also known as p44 and p42 MAPK respectively are important proteins in the MAP kinase signaling pathway. They are expressed in various tissues with significant presence in the brain lungs and skin. ERK1 has a molecular weight of approximately 44 kDa while ERK2 has a molecular weight of around 42 kDa. Both proteins become activated through phosphorylation which is essential for their function in cellular processes.
Biological function summary

ERK1 and ERK2 serve as key players in cellular growth differentiation and survival. They form part of a complex cascade where they transduce signals from the cell membrane to the nucleus after activation by phosphorylation. This phosphorylation enables them to modify various downstream targets involved in regulating gene expression and cellular response to external stimuli.

Pathways

ERK1 and ERK2 are critical components of the MAPK/ERK pathway and the Ras-Raf-MEK-ERK signaling cascade. These pathways regulate a multitude of cellular activities including proliferation and differentiation. In the MAPK/ERK pathway proteins like Ras and Raf serve as upstream activators of ERK1 and ERK2. Both ERK1 and ERK2 also interact with other signaling proteins such as MEK1/2 which directly phosphorylates and activates them.

Dysregulation of ERK1 and ERK2 is associated with various pathologies including cancer and neurodegenerative diseases. Abnormal activation of these proteins often leads to uncontrolled cell proliferation contributing to oncogenesis. For instance mutations in proteins like Ras which regulate ERK1 and ERK2 can result in continuous activation and lead to tumor formation. Furthermore altered ERK1 and ERK2 signaling is linked to neurodegeneration impacting neuronal survival and function.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Serine/threonine kinase which acts as an essential component of the MAP kinase signal transduction pathway. MAPK1/ERK2 and MAPK3/ERK1 are the 2 MAPKs which play an important role in the MAPK/ERK cascade. They participate also in a signaling cascade initiated by activated KIT and KITLG/SCF. Depending on the cellular context, the MAPK/ERK cascade mediates diverse biological functions such as cell growth, adhesion, survival and differentiation through the regulation of transcription, translation, cytoskeletal rearrangements. The MAPK/ERK cascade also plays a role in initiation and regulation of meiosis, mitosis, and postmitotic functions in differentiated cells by phosphorylating a number of transcription factors. About 160 substrates have already been discovered for ERKs. Many of these substrates are localized in the nucleus, and seem to participate in the regulation of transcription upon stimulation. However, other substrates are found in the cytosol as well as in other cellular organelles, and those are responsible for processes such as translation, mitosis and apoptosis. Moreover, the MAPK/ERK cascade is also involved in the regulation of the endosomal dynamics, including lysosome processing and endosome cycling through the perinuclear recycling compartment (PNRC); as well as in the fragmentation of the Golgi apparatus during mitosis. The substrates include transcription factors (such as ATF2, BCL6, ELK1, ERF, FOS, HSF4 or SPZ1), cytoskeletal elements (such as CANX, CTTN, GJA1, MAP2, MAPT, PXN, SORBS3 or STMN1), regulators of apoptosis (such as BAD, BTG2, CASP9, DAPK1, IER3, MCL1 or PPARG), regulators of translation (such as EIF4EBP1 and FXR1) and a variety of other signaling-related molecules (like ARHGEF2, DCC, FRS2 or GRB10). Protein kinases (such as RAF1, RPS6KA1/RSK1, RPS6KA3/RSK2, RPS6KA2/RSK3, RPS6KA6/RSK4, SYK, MKNK1/MNK1, MKNK2/MNK2, RPS6KA5/MSK1, RPS6KA4/MSK2, MAPKAPK3 or MAPKAPK5) and phosphatases (such as DUSP1, DUSP4, DUSP6 or DUSP16) are other substrates which enable the propagation the MAPK/ERK signal to additional cytosolic and nuclear targets, thereby extending the specificity of the cascade. Mediates phosphorylation of TPR in response to EGF stimulation. May play a role in the spindle assembly checkpoint. Phosphorylates PML and promotes its interaction with PIN1, leading to PML degradation. Phosphorylates CDK2AP2 (By similarity).. Acts as a transcriptional repressor. Binds to a [GC]AAA[GC] consensus sequence. Repress the expression of interferon gamma-induced genes. Seems to bind to the promoter of CCL5, DMP1, IFIH1, IFITM1, IRF7, IRF9, LAMP3, OAS1, OAS2, OAS3 and STAT1. Transcriptional activity is independent of kinase activity.
See full target information MAPK1 phospho Y187

Additional targets

MAPK1 phospho Y187

Publications (27)

Recent publications for all applications. Explore the full list and refine your search

Heliyon 9:e17120 PubMed37360090

2023

Circular RNA circBNC2 facilitates glycolysis and stemness of hepatocellular carcinoma through the miR-217/high mobility group AT-hook 2 (HMGA2) axis.

Applications

Unspecified application

Species

Unspecified reactive species

Yan Feng,Shufeng Xia,Junlan Hui,Yan Xu

Pathologica 114:128-137 PubMed35481563

2022

Immunohistochemical assessment of cannabinoid type-1 receptor (CB1R) and its correlation with clinicopathological parameters in glioma.

Applications

Unspecified application

Species

Unspecified reactive species

Nader Choucair,Zahraa Saker,Hassane Kheir Eddine,Hisham F Bahmad,Youssef Fares,Mariana Zaarour,Hayat Harati,Sanaa Nabha

Bosnian journal of basic medical sciences 22:217-228 PubMed34813418

2022

Protocatechuic acid as an inhibitor of the JNK/CXCL1/CXCR2 pathway relieves neuropathic pain in CCI rats.

Applications

Unspecified application

Species

Unspecified reactive species

Hong-Xia Chang,Yue-Feng Zhao

Cells 10: PubMed33799631

2021

The G-Protein-Coupled Estrogen Receptor (GPER) Regulates Trimethylation of Histone H3 at Lysine 4 and Represses Migration and Proliferation of Ovarian Cancer Cells In Vitro.

Applications

Unspecified application

Species

Unspecified reactive species

Nan Han,Sabine Heublein,Udo Jeschke,Christina Kuhn,Anna Hester,Bastian Czogalla,Sven Mahner,Miriam Rottmann,Doris Mayr,Elisa Schmoeckel,Fabian Trillsch

Journal of cancer research and clinical oncology 146:2189-2203 PubMed32488496

2020

Prostaglandin E2 receptor 3 (EP3) signaling promotes migration of cervical cancer via urokinase-type plasminogen activator receptor (uPAR).

Applications

Unspecified application

Species

Unspecified reactive species

Yao Ye,Lin Peng,Aurelia Vattai,Eileen Deuster,Christina Kuhn,Christian Dannecker,Sven Mahner,Udo Jeschke,Viktoria von Schönfeldt,Helene H Heidegger

Molecular medicine reports 22:895-905 PubMed32626978

2020

Downregulation of miRNA‑328 promotes the angiogenesis of HUVECs by regulating the PIM1 and AKT/mTOR signaling pathway under high glucose and low serum condition.

Applications

Unspecified application

Species

Unspecified reactive species

Yan Zou,Fei Wu,Qi Liu,Xian Deng,Rui Hai,Xuemei He,Xiangyu Zhou

International journal of oncology 57:197-212 PubMed32319593

2020

G6PD facilitates clear cell renal cell carcinoma invasion by enhancing MMP2 expression through ROS‑MAPK axis pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Qiao Zhang,Qiaoqiao Han,Zhe Yang,Yueli Ni,Yannick Luther Agbana,Honggang Bai,Zihan Yi,Xiaojia Yi,Yingmin Kuang,Yuechun Zhu

Open life sciences 14:528-536 PubMed33817189

2019

Immune Negative Regulator TIPE2 Inhibits Cervical Squamous Cancer Progression Through Erk1/2 Signaling.

Applications

Unspecified application

Species

Unspecified reactive species

Li-Qiong Huang,Bo Zheng,Yi He

Journal of cellular biochemistry 122:958-968 PubMed31773798

2019

Role of miR-106-mediated mitogen-activated protein kinase signaling pathway in oxidative stress injury and inflammatory infiltration in the liver of the mouse with gestational hypertension.

Applications

Unspecified application

Species

Unspecified reactive species

Zhihui Wang,Xiufang Bao,Limeng Song,Yuying Tian,Ping Sun

Biomolecules 9: PubMed31717401

2019

7--methylpunctatin, a Novel Homoisoflavonoid, Inhibits Phenotypic Switch of Human Arteriolar Smooth Muscle Cells.

Applications

Unspecified application

Species

Unspecified reactive species

Manal Fardoun,Rabah Iratni,Hassan Dehaini,Assaad Eid,Tarek Ghaddar,Tamam El-Elimat,Feras Alali,Adnan Badran,Ali H Eid,Elias Baydoun
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com